期刊文献+

维血宁对环磷酰胺致骨髓抑制模型小鼠的WBC、RBC、PLT和Hb的影响 被引量:6

Effect of Weixuening on WBC,RBC,PLT and Hb of myelosuppression mice induced by cyclophosphamide
下载PDF
导出
摘要 目的观察维血宁对环磷酰胺致骨髓抑制模型小鼠的治疗作用。方法采用腹腔注射环磷酰胺引起小鼠骨髓抑制。将模型动物随机分组,各组分别给予维血宁41.3,20.6和10.3 g.kg-1,以及升血小板胶囊和白介素-11,连续14 d,末次给药后2 h,取血,进行血液学检查,测定出血、凝血时间。结果维血宁能不同程度地升高模型动物WBC、PLT、RBC和Hb,其中维血宁各剂量组动物WBC、PLT、Hb与模型组比较,差异有统计学意义(P<0.05或<0.01);维血宁大、小剂量组动物RBC与模型组比较,差异有统计学意义(P<0.01);维血宁组动物的出血、凝血时间较模型组缩短(P<0.01或<0.05)。结论维血宁对环磷酰胺致骨髓抑制模型小鼠具有治疗作用,能升高外周血WBC、RBC、PLT和Hb。 Objective To investigate the therapeutic effects of Weixuening on myelosuppression mice induced by cyclophosphamide (CTX). Method The myelosuppression mice models were induced by CTX. In addition to normal control group, the myelosuppression mice were randomly divided into 6 groups:model group,Weixuening groups (ig 41.3,20.6 and 10.3 g· kg^-1 ), Sheng Xuexiaoban Jiaonang group (ig 1. 125 g · kg^-1 ) and IL-11 group lip 250μg · kg^-1 ). Each group were given homologous medicine once a day. The amount of ceils and Hb of peripheral blood of the mice were detected at 2 hours of after 14 days treatment. Result The Weixuening can increase the WBC,RBC,PLT and Hb of peripheral blood of mice. The WBC,PLT and Hb of mice of Weixuening 3 dosage groups were higher than that of model group ( P 〈0.05 or P 〈0.01). The RBC of Weixuening high and low dosage groups were also higher(P 〈0.01 ). The bleeding time and cruor time of Weixuening groups were shorter than that of model group ( P 〈0.05 or P 〈0.01). Conclusion The Weixuening can cure the myelosuppression induced by CTX and increase WBC, RBC,PLT and Hb of peripheral blood of mice.
出处 《西北药学杂志》 CAS 2011年第5期354-356,共3页 Northwest Pharmaceutical Journal
基金 陕西省重大科技创新项目(编号:2009ZKC05-05)
关键词 维血宁 环磷酰胺 骨髓抑制 Weixuening cyclophosphamide myelosuppression
  • 相关文献

参考文献5

二级参考文献9

  • 1张子南.血液病诊断及疗效标准[M].天津:天津科学技术出版社,2000:119.
  • 2Leonard JP,Quinto CM,Kozitza MK.Recombinant human interleukin-11 stimulates multilineage hematopoietic recovery in mice after a myelosuppressive regiment of sublethal irradiation and carboplatin [J].Arch Ophthalmol ,1998,116(9):1209-1212.
  • 3Isaacs C,Battiato L.Randomized placebo-controlled study of recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with breast cancer receiving dose-intensive cyclophosphamide and doxorubicin [J].J Clin Oncol,1997,15(11):3368-3377.
  • 4Franklin J,Schlerman,Andrea G,et al.Thrombopoietic Activity of recombinant human interleukin 11(rhIL-11) in Normal and myelosuppressed nonhuman primates[J].Stem Cells,1996,14:517-532.
  • 5Nash R,Seidel K,Strob R.Effects of rhIL-11 on normal dogs and after subletal radiation [J].Exp Hematol,1995,23:389-396.
  • 6孙燕,周际昌.临床肿瘤内科手册[M]人民卫生出版社,1996.
  • 7张建华,严晓春,吴云.重组人白介素-11治疗化疗所致血小板减少的临床观察[J].临床肿瘤学杂志,2009,14(5):452-453. 被引量:12
  • 8何学令,尹海林,刘学旭.血小板减小症模型制作及药效试验应用研究[J].四川动物,2003,22(2):121-122. 被引量:4
  • 9张擎,彭红娟,余晓彬,徐培林.环磷酰胺诱发小鼠血小板减少症模型的建立及其血小板功能的测定[J].第一军医大学学报,2003,23(12):1277-1279. 被引量:25

共引文献27

同被引文献53

引证文献6

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部